PNB Housing shelves ₹ 4,000-cr share sale plan to Carlyle Group, other investors

[ad_1]

Read More/Less


PNB Housing Finance Limited (PNBHFL) has called off it’s proposed ₹ 4,000 crore share sale plan to Carlyle Group and other marquee investors including General Atlantic and Ares SSG, citing protracted delays and uncertainty over regulatory approvals required for the preferential issue.

At a Board meeting held on Thursday evening, PNBHFL decided not to proceed with the proposed preferential issue and therefore will now evaluate other alternatives to raise capital.

Also, all the share subscription agreements executed with the proposed allottees have been terminated.

SAT’s split verdict leaves PNB-Carlyle deal in limbo; case may go to apex court

Under the proposed deal, Pluto Investments S.a.r.l, an affiliated entity of Carlyle Asia Partners IV , L.P and Carlyle Asia Partners V, L.P (together , “Carlyle”) had agreed to invest upto ₹ 3,185 crore through a preferential allotment of equity shares and warrants, at a price of ₹ 390 per share. Existing shareholders of PNBHFL, funds managed by Ares SSG and General Atlantic were also to participate in the capital raise. Salisbury Investments (Former HDFC Bank CEO Aditya Puri’s family investment vehicle) was also part of the capital raise deal. PNB had earlier decided that it will not be participating in the capital raise but would continue to be promoter of PNBHFL.

Legal issues

However, the deal ran into rough weather in June after SEBI intervened and asked PNBHFL not to go ahead with the deal until the housing finance company undertakes valuation of its shares by an independent agency. PNBHFL preferred an appeal before Securities Appellate Tribunal ( SAT), which came with a split verdict on August 9. SEBI has preferred an appeal against the SAT verdict before the Supreme Court, which is pending.

Meanwhile, in a filing to the stock exchanges on Thursday night, PNBHFL said this proposed preferential issue has been held up for more than four months (after already having taken over two years), due to pending legal proceeding before the SAT. There continues to be no visibility or certainty as to the timeline for judicial determination of the legal issues, in particular as a third member of the SAT is yet to be appointed, PNBHFL said.

Noting that due to protracted litigation and the continuing interim order of the SAT dated June 21, there is no clarity on the shareholders approval for undertaking the preferential issue. In addition, regulatory approvals required for the preferential issue, are pending and it is unclear whether such approvals will be forthcoming while the legal proceedings are ongoing. Therefore, the company’s capital raising plans will be further delayed and such uncertainty will continue.

PNBHFL said that the Board’s primary objective is to raise capital to support the growth of the company and the Board believes that the current situation is not in the best interest of the company and its stakeholders. Accordingly, the Board has decided not to proceed with the preferential issue.

Consequently, Pluto Investments S.a.r.l ( together with persons acting in concert) will be initiating the process to withdraw the open offer made by them ( at ₹ 403.22 per share) in accordance with the SEBI Takeover code.

Interestingly, the Competition Commission of India had in early August approved (deemed approval under green channel) the Carlyle Group led ₹ 4,000 crore equity investment transaction in PNBHFL even as SAT was then yet to pronounce its verdict on the valuation controversy.

[ad_2]

CLICK HERE TO APPLY

Carlyle Group exits SBI Life Insurance Company, BFSI News, ET BFSI

[ad_1]

Read More/Less


NEW DELHI: Private equity firm Carlyle Group has exited SBI Life Insurance Company Ltd by selling its stake representing 1.9 per cent shareholding of the company, through open market transactions.

The total deal value stood at Rs 2,147 crore.

As per the BSE’s block deal data for Thursday, Carlyle Group through its entity, CA Emerald Investments, sold a total of 1.9 crore scrips at an average price of Rs 1,130 per scrip.

SBI Life Insurance Company’s shareholding data for the June 2021 quarter showed that CA Emerald Investments was its public shareholder and held 1.9 per cent stake in the firm.

Separately, the shares were picked up by Max Life Insurance Company Ltd, Morgan Stanley Asia Singapore Pte, HDFC Standard Life Insurance, BNP Paribas Arbitrage, Bofa Securities Europe SA, Societe Generale, Integrated Core Strategies (Asia) Pte Ltd.

The shares were also picked up by a host of mutual funds including Kotak Mahindra Mutual Fund, Pioneer Investment Fund, Nippon Indian Mutual Fund, Franklin Templeton Mutual Fund, SBI Mutual Fund and ICICI Prudential Mutual Fund, among others.

On the BSE, SBI Life Insurance Company on Friday opened the counter at Rs 1,147 and had ended at Rs 1,134.85 on Thursday.



[ad_2]

CLICK HERE TO APPLY

CCI green signals Carlyle Group-led ₹4,000 cr investment in PNB Housing

[ad_1]

Read More/Less


The Competition Commission of India (CCI) has approved the Carlyle Group-led ₹4,000 crore equity investment transaction in PNB Housing Finance Ltd ( PNBHFL) even as the Securities and Appellate Tribunal (SAT) is yet to pronounce its verdict on the valuation controversy that the deal ran into recently.

Giving its “deemed approval” to the green channel notice on the combination —which involves Carlyle Group controlled Pluto Investments S.a.r.l and Salisbury Investments (Aditya Puri’s family investment vehicle) acquiring upto 56.29% stake (assuming full tendering and acceptance in the open offer), the competition watchdog CCI noted that the proposed combination raises no risk of any appreciable adverse effect on competition under the competition law.

Under the deal announced on May 31, Carlyle Group alongside other investors were to infuse ₹4,000 crore capital into PNBHFL through preferential allotment of equity shares and warrants at ₹390 per share. However, this deal ran into rough weather after SEBI intervened and asked PNBHFL not to go ahead with the deal until the Housing Finance company undertakes valuation of its shares by an independent agency.

PNBHFL later preferred an appeal before the SAT, which has reserved its order.

As part of the deal, Pluto Investments had agreed to invest upto ₹3,185 crore. The proposed Carlyle-led transaction will trigger a mandatory open offer by Pluto Investments S.a.r.l. for the purchase of up to 26 per cent equity shares of PNBHFL from public shareholders.

On Wednesday, shares of PNBHFL closed 5 per cent higher at ₹717.85 at National Stock Exchange.

[ad_2]

CLICK HERE TO APPLY

HDFC Bank | Aditya Puri: Former HDFC Bank MD Aditya Puri joins global pharma major Strides Group as advisor, BFSI News, ET BFSI

[ad_1]

Read More/Less


Former HDFC Bank managing director Aditya Puri has joined global pharma major Strides Group as an advisor and will also serve as a director of its associate company Stelis Biopharma. “Eminent corporate doyen Aditya Puri joins the Strides Group as an advisor and also will be a director of its associate company, Stelis Biopharma,” Strides Pharma Science said in a regulatory filing.

Strides Pharma Science said Puri’s appointment to the Stelis board comes at an exciting juncture for the company as it transitions from its incubation phase to a consolidation and growth phase to establish itself as a partner of choice globally with the aim of bringing world-class treatments at affordable costs to patients in both emerging and developed markets.

On his appointment, Puri said the Stride Group’s established parentage, global success and headstart in terms of basic infrastructure gives him the opportunity to be involved in and guide Stelis and other Group endeavours in their exciting growth story.

Arun Kumar, Founder and Chairman of the Board of Strides, said: “I am delighted to welcome Aditya as our advisor and to the Stelis board. This a huge vote of confidence in the potential of Stelis. Aditya’s illustrious legacy is well-known. Having nurtured HDFC Bank since inception, his deep experience will be extremely valuable for the Strides Group and Stelis in particular.

“With Stelis poised for its next leg of growth, this is the right time to expand the board, and ensure robust guidance and governance by the best possible industry minds. I look forward to working with Aditya and leveraging his expertise to take Stelis to new heights”.

Puri, who led HDFC Bank since its inception over 25 years ago, retired in October 2020, after a highly successful career which has made the bank the largest among private sector lenders.

While heading a foreign bank’s operations in Malaysia in the early 1990s, Puri got an offer from Deepak Parekh of mortgage major HDFC to come back to India to start a bank in an economy which had shifted gears with liberalisation moves.

In November 2020, Puri was roped in by US-based global investment firm Carlyle Group as a senior advisor.



[ad_2]

CLICK HERE TO APPLY